Robin Young - Profile and Journalist Details

Find journalists that align with your industry, location and vision. Unlock Robin Young's full journalist profile, including location, coverage topics, current employer, biography and preferences. Sign up today and start building journalist relationships that fuel your startup's growth.

Get connected with journalists today
Robin Young

Robin Young

Verified

Chief Executive Officer, Orthopedics This Week

Portland

Final Covers

Life Sciences , Health Equity, Biotech Innovations , RNA Vaccines, Climate Change , Biology , Health, Science Policy

Doesn’t Cover

Happy to look at all ideas/pitches.

Journalist Type

Seniority Positions

Industries

Medium Formats

Content

Total articles 15

  • Keith Valentine Is Barricaid’s New CEO

    By Robin Young| Orthopedics This Week Verified Intrinsic Therapeutics, Inc., whose lead product, Barricaid, is as well known, possibly better known than the company, has a new CEO—57-year-old Keith Valentine. Intrinsic Therapeutics, founded in 2000 in Woburn, Massachusetts, markets the Barricaid® annular prosthesis to prevent reherniation and reoperation in patients with large annulus defects following lumber discectomy surgery. Barricaid reduces reoperations for reherniations for lumbar discectomy patients with large annular defects by 81%.

    By Robin Young · Orthopedics This Week

    Apr. 15, 2025

  • Hospital Outlook, No Coverage for Ozempic, and Start-up Investing

    By Robin Young| Orthopedics This Week Verified Hospital 2025 OutlookWells Fargo’s Wall Street research team just released a very enlightening interview with one of the largest health systems in the United States—the 1,300 bed, 7 hospital, 5 JV hospital and 2 ASC Methodist Health System in the Dallas-Fort Worth area. We’re talking 60% inpatient/40% outpatient mix with approximately 40-50,000 surgeries annually.

    By Robin Young · Orthopedics This Week

    Apr. 09, 2025

  • Keith Valentine Is Barricaid’s New CEO

    By Robin Young| Orthopedics This Week Verified Intrinsic Therapeutics, Inc., whose lead product, Barricaid, is as well known, possibly better known than the company, has a new CEO—57-year-old Keith Valentine. Intrinsic Therapeutics, founded in 2000 in Woburn, Massachusetts, markets the Barricaid® annular prosthesis to prevent reherniation and reoperation in patients with large annulus defects following lumber discectomy surgery. Barricaid reduces reoperations for reherniations for lumbar discectomy patients with large annular defects by 81%.

    By Robin Young · Orthopedics This Week

    Apr. 15, 2025

As seen in

Company Info

Orthopedics This Week

Orthopedics This Week is a prominent publication in the orthopedic industry, established in 2004 and based in Lansdale, Pennsylvania. It specializes in book and periodical publishing, focusing on topics such as orthopedics, spine, sports medicine, and orthopedic surgery. The publication is known for delivering breaking news, analysis, and commentary 40 times a year, covering a wide range of subjects from stem cells to medical tourism. In addition to its publication, Orthopedics This Week hosts innovative technology conferences and publishes quarterly Market Forecasts and Analysis. The company provides valuable insights into orthopedic devices, research, and care, serving a diverse audience that includes surgeons, medical device professionals, clinicians, and researchers. With approximately $10 million in revenue and a dedicated team of around 16 employees, Orthopedics This Week is recognized for its journalistic excellence and is a trusted source for industry news and education.

Lansdale, Pennsylvania, United States

'+1 888-352-1952

Founded: 2004